Banned brain drug trial seeks to lift depression curse
NCT ID NCT04249596
Summary
This study tested tianeptine, an antidepressant used in other countries but not approved in the US, for people with major depression that hasn't improved after trying at least two other standard treatments. Participants took the drug for 8 weeks while researchers measured changes in their depression symptoms. The study also used brain scans and genetic tests to try to understand why some people don't respond to current antidepressants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
New York State Psychiatric Institute
New York, New York, 10032, United States
-
Stanford Depression Research Clinic at Stanford University School of Medicine
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.